Official ACTA Text Released

A prepared-for-the-public version of the Anti-Counterfeiting Trade Agreement under negotiation by leading economies has now been released online. The release comes after increased public and civil society outcry over a non-transparent negotiating process and fears that the treaty would lead…

Geneva Health Forum Addresses Biotech, Trade, Pandemic Flu

Biotechnology, international trade, and pandemic influenza were among the topics discussed at the outset of this year’s Geneva Health Forum.

Open Source Company Alleges IBM Antitrust; IBM Requests Analysis

Computer giant IBM is facing an antitrust claim before the European Commission brought by an open source software company alleging that IBM is preventing customers from using that software. Meanwhile, the open source community is worried that the use of intellectual property rights by IBM - a leading open source software maker – to block a competitor will endanger free and open source software and might uncap other IP rights claims from other players. IBM, for its part, is reaffirming its support to open source community and has asked the competing company to explain how its software does not infringe on IBM IP rights.

WIPO, WTO Requested To Advise On Anti-Counterfeiting Treaty

Several members of the European Parliament today sent letters to the directors general of the World Intellectual Property Organization and the World Trade Organization requesting technical assistance in the negotiation of an agreement that some are calling an attempt to circumvent global norms on intellectual property enforcement and related public interest flexibility.

Committee Examines Undue Influence, Coordination In WHO Pandemic Flu Response

A review of the World Health Organization’s response to the 2009 pandemic influenza outbreak kicked off this week, with firm statements from those involved in the response that they were not unduly influenced by outside stakeholders. Still, serious questions remain about the coordination effort, as a nearly a year after the pandemic was declared developed countries find themselves having to dispose of excess vaccines while poorer countries are reporting they have yet to obtain as many as they need.